National cost estimation of maoto, a Kampo medicine, compared with oseltamivir for the treatment of influenza in Japan

Publisher： John Wiley & Sons Inc

E-ISSN： 2053-4515|3|1|59-62

ISSN： 2053-4515

Source： Traditional & Kampo Medicine, Vol.3, Iss.1, 2016-04, pp. : 59-62

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Cost Effectiveness of Oseltamivir Treatment for Patients with Influenza-Like Illness Who Are at Increased Risk for Serious Complications of Influenza: Illustration for The Netherlands

By Postma Maarten J.  

PharmacoEconomics, Vol. 25, Iss. 6, 2007-01 ,pp. : 497-509

Adis International

Access to resources Recommend Favorite

Oseltamivir for treatment and prophylaxis of influenza infection

By Schirmer Patricia   Holodniy Mark  

Expert Opinion on Drug Safety, Vol. 8, Iss. 3, 2009-05 ,pp. : 357-371

Informa Healthcare

Access to resources Recommend Favorite

Oseltamivir cost effective for post-exposure prophylaxis of influenza

By  

Inpharma, Vol. 1, Iss. 1537, 2006-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Oseltamivir: finding a place in the influenza treatment arena

By  

Inpharma, Vol. 1, Iss. 1248, 2000-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

"Zanamivir is more effective than oseltamivir for the treatment of influenza B"

By  

Inpharma, Vol. 1, Iss. 1591, 2007-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite